GLP-1 receptor agonists, such as semaglutide and liraglutide, are increasingly prescribed for type 2 diabetes and weight management in the UK
Researchers suggested that this difference was likely due to altered drug processing in the body, rather than more aggressive disease alone, raising the possibility that weight normalization could improve treatment effectiveness, says Ali
Before making any changes to your GLP-1 medication management, consider these factors: Current treatment response: If your injectable medication is working well, switching may not offer additional benefits Lifestyle compatibility: The empty stomach requirement and 30-minute waiting period requires consistent daily scheduling Cost considerations: Insurance coverage for the pill may differ from injectable coverage initially Other medications: The timing restrictions may complicate existing medication schedules Optimizing Your Results: Beyond the Medication Whether you choose oral or injectable GLP-1 treatment, medication alone isnt the complete picture
Shigeoka T, Nomiyama T, Kawanami T, Hamaguchi Y, Horikawa T, Tanaka T, et al
Understanding which neurotransmitter system is primarily affected can help guide treatment decisions, something we will explore in the strategies section below
